The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health

SARS-CoV-2 is unlikely to be detected in human semen, but viral tropism for the male reproductive tract and the impact on both male hormones and semen parameters remains incompletely characterized.

Like Comment
Related Content

VOLUME 115, ISSUE 4, P813-823

Authors:

Darshan P. Patel, M.D., Nahid Punjani, M.D., MPH, Jingtao Guo, Ph.D., Joseph P. Alukal, M.D., Philip S. Li, M.D., James M. Hotaling, M.D., MS 

Abstract:

Many couples initially deferred attempts at pregnancy or delayed fertility care due to concerns about coronavirus disease 2019 (COVID-19). One significant fear during the COVID-19 pandemic was the possibility of sexual transmission. Many couples have since resumed fertility care while accepting the various uncertainties associated with severe acute respiratory syndrome coronavirus 2, including the evolving knowledge related to male reproductive health. Significant research has been conducted exploring viral shedding, tropism, sexual transmission, the impact of male reproductive hormones, and possible implications to semen quality. However, to date, limited definitive evidence exists regarding many of these aspects, creating a challenging landscape for both patients and physicians to obtain and provide the best clinical care. This review provides a comprehensive assessment of the evolving literature concerning COVID-19 and male sexual and reproductive health, and guidance for patient counseling.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.